Evidence map›Paper›PMID 42036234›Full record

ReviewZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2026

[Research advances of magnetic resonance elastography for assessing the bioinvasiveness in hepatocellular carcinoma].

M Y Ma, R K Li

Abstract readReviewEnglish Abstract
In one paragraph

Review in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

M Y MaDepartment of Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
R K LiDepartment of Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

Funding

National Natural Science Foundation of China 82471939
6 · The paper itself

Abstract

The invasiveness of hepatocellular carcinoma (HCC) is closely correlated with the dynamic changes in the biomechanical microenvironment. The solid (e.g., tissue sclerosis due to stromal fibrosis) and fluid mechanics processes (e.g., disordered interstitial hydraulic gradient) of HCC are significantly aberrant in comparison to normal liver tissue. These mechanical characteristics synergistically promote tumor invasion and metastasis by regulating mechanosensitive pathways and forming an interaction network with key biochemical signals. Magnetic resonance elastography (MRE), as a non-invasive technique, enables quantitative assessment of the mechanical heterogeneity of HCC by accurately characterizing tissue viscoelastic indices (e.g., shear modulus and loss modulus). Several studies have confirmed that MRE parameters are strongly correlated with tumor differentiation grade, microvascular invasion status, and molecular phenotypes (e.g., high Ki-67 expression and phosphatidylinositol proteoglycan 3 targeting). Furthermore, MRE's quantitative assessment of tumor hardness can provide objective support for prognostic stratification by accurately predicting the likelihood of postoperative recurrence. The non-invasive, reproducible, and quantitative advantages of MRE, which are based on the invasive assessment of HCC, demonstrate its unique clinical value. Multidimensional information in support of conventional imaging and molecular marker evaluation facilitates the early-stage diagnosis, personalized treatment, and dynamic monitoring of HCC.

Indexed as

Carcinoma, HepatocellularElasticity Imaging TechniquesLiver NeoplasmsMagnetic Resonance ImagingHumansNeoplasm Invasiveness

Identifiers

PMID42036234
PMCPMC13153946

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.